News|Videos|November 18, 2026

Parenteral nutrition in preterm infants: Balancing benefits and risks

Key Takeaways

  • Advances in neonatal care have increased survival among extremely preterm infants, highlighting the need to reassess parenteral nutrition practices using contemporary evidence.
  • Evidence suggests that intravenous amino acid doses exceeding approximately 3.5 g/kg/day may increase the risk of morbidity in preterm infants.
SHOW MORE

Daniel Robinson, MD, discusses evidence-based parenteral nutrition practices, amino acid dosing, and opportunities to improve NICU protocols.

Advances in neonatal intensive care have changed the population of preterm infants receiving parenteral nutrition (PN), raising questions about whether longstanding nutritional practices adequately reflect the needs of today's patients, according to Daniel Robinson, MD.

Robinson, associate professor of pediatrics at Northwestern University Feinberg School of Medicine and attending neonatologist at Lurie Children's Hospital and Prentice Women's Hospital, discussed evidence-based PN recommendations and opportunities to improve neonatal nutrition practices in an interview with Contemporary Pediatrics.

He emphasized the importance of evaluating current evidence, understanding guideline limitations, and reassessing institutional protocols to optimize nutritional support while minimizing potential harm.

Why do parenteral nutrition practices need reassessment?

Robinson explained that the population of infants receiving PN has changed substantially since many intravenous nutrition formulations were originally developed.

Extremely preterm infants who may not have survived several decades ago are now routinely cared for in neonatal intensive care units (NICUs).

"I think one very important consideration is that the infants that we are caring for in the neonatal intensive care unit now are a good bit different in meaningful ways, as compared to the decades ago, when the formulations or the mixtures of parenteral or IV nutrition were tested and being developed," Robinson said.

These changes highlight the need for updated research examining how extremely preterm infants metabolize and use intravenously administered nutrients.

Robinson emphasized that current clinical practices should reflect evidence derived from populations representative of infants receiving treatment today.

How does the GRADE framework strengthen nutrition recommendations?

Robinson highlighted the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework as an important tool for evaluating evidence underlying clinical guidelines.

The framework provides a structured, transparent approach to assessing research findings and developing recommendations.

For clinicians, understanding that guidelines were developed using GRADE can provide greater confidence in the rigor of the evaluation process.

Robinson also emphasized that recommendations should communicate the certainty of the supporting evidence, allowing clinicians to understand the limitations of available research.

This distinction is particularly important when applying nutrition recommendations to vulnerable neonatal populations, where evidence may be limited or evolving.

What should clinicians consider when prescribing parenteral nutrition?

Robinson emphasized that clinicians must first determine whether guideline recommendations apply to the infants they are treating.

He noted that the American Society for Parenteral and Enteral Nutrition (ASPEN) guidelines focus on preterm infants without primary surgical disease.

Infants with intestinal surgical conditions may also require PN, but their nutritional needs may differ from those of the populations included in the supporting studies.

"I think that's an important step. One, make sure that we're applying these recommendations to the right infants," Robinson said.

Amino acid dosing represents another important consideration.

Robinson explained that evidence reviewed during guideline development, along with subsequent meta-analyses, suggests potential risks associated with higher intravenous amino acid doses.

"When you start giving more IV amino acids, you could very well be creating situations of potential harm and increased risk of morbidity for preterm infants," he said.

He identified approximately 3.5 g/kg/day as an important threshold, cautioning that exceeding this amount may increase the likelihood of adverse outcomes.

The findings challenge the assumption that providing greater quantities of nutrients necessarily improves neonatal outcomes.

How can NICU teams improve parenteral nutrition practices?

Robinson recommended that NICU teams start by reviewing existing institutional PN protocols, especially nutrient-dosing recommendations.

He emphasized that this process should involve a multidisciplinary team, not just physicians.

Dietitians, pharmacists, nurse practitioners, and other frontline clinicians contribute different perspectives to nutrition prescribing, preparation, and administration.

"I think one of the most important things that anyone can do is to intensively review your local protocols," Robinson said.

A collaborative review can help institutions identify discrepancies between local practices and current evidence-based recommendations.

Robinson emphasized that incorporating multiple clinical perspectives is essential for developing protocols that are practical, consistent, and appropriate for the infants receiving care.

For neonatal clinicians, his recommendations underscore the importance of individualized PN prescribing, careful attention to amino acid dosing, and regular reassessment of institutional practices as the evidence continues to evolve.

Reference
Robinson D. A report card on parenteral nutrition practices for optimal outcomes in preterm infants: what is the GRADE? Presented at: Hot Topics in Neonatology; December 12, 2026.

Related to this article